ea0032p760 | Obesity | ECE2013
Sauer Nina
, Rohani Zaina
, Wiesch Clarissa Schulze zur
, Reining Franziska
, Aberle Jens
Context: Recent data from controlled clinical trials have demonstrated that GLP-1 agonists are a well-tolerated therapy-option for weight loss in obese patients without type 2 diabetes mellitus.Objective: To investigate whether continuation of treatment, side-effects and effect on weight loss of GLP-1 agonists are equally promising in dairy clinical practice settings in non-diabetics.Methods: Obese, non-diabetic patients of our int...